{"name": "Orphazyme",
 "permalink": "orphazyme",
 "crunchbase_url": "http://www.crunchbase.com/company/orphazyme",
 "homepage_url": "http://www.orphazyme.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@orphazyme.com",
 "phone_number": "",
 "description": "",
 "created_at": "Mon Mar 28 01:25:55 UTC 2011",
 "updated_at": "Thu Sep 08 02:46:41 UTC 2011",
 "overview": "\u003Cp\u003EOrphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja J\u00c3\u00a4\u00c3\u00a4ttela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kr\u00c3\u00a6ftens Bek\u00c3\u00a6mpelse). Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       31],
      "assets/images/resized/0012/8021/128021v1-max-150x150.png"],
     [[250,
       51],
      "assets/images/resized/0012/8021/128021v1-max-250x250.png"],
     [[386,
       80],
      "assets/images/resized/0012/8021/128021v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Anders",
      "last_name": "M\u00c3\u00b8rkeberg Hinsby",
      "permalink": "anders-mrkeberg-hinsby",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$20M",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.orphazyme.com/news",
    "source_description": "Orphazyme raises 22 mDKK in a seed round extension; Sunstone Capital joins as new investor ",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2011,
    "funded_month": 2,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sunstone Capital",
         "permalink": "sunstone-capital",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0003/0832/30832v2-max-150x150.png"],
             [[216,
               66],
              "assets/images/resized/0003/0832/30832v2-max-250x250.png"],
             [[216,
               66],
              "assets/images/resized/0003/0832/30832v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.fiercebiotech.com/story/orphazyme-lands-20m-round-back-new-drugs-rare-genetic-disorder/2011-09-07?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Orphazyme lands $20M A round to back new drugs for rare genetic disorder",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 9,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aescap Venture",
         "permalink": "aescap-venture",
         "image":
          {"available_sizes":
            [[[150,
               100],
              "assets/images/resized/0004/9289/49289v3-max-150x150.png"],
             [[157,
               105],
              "assets/images/resized/0004/9289/49289v3-max-250x250.png"],
             [[157,
               105],
              "assets/images/resized/0004/9289/49289v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sunstone Capital",
         "permalink": "sunstone-capital",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0003/0832/30832v2-max-150x150.png"],
             [[216,
               66],
              "assets/images/resized/0003/0832/30832v2-max-250x250.png"],
             [[216,
               66],
              "assets/images/resized/0003/0832/30832v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Ole Maal\u00c3\u00b8s Vej 3",
    "address2": "",
    "zip_code": "DK-2200 ",
    "city": "Copenhagen N",
    "state_code": null,
    "country_code": "DNK",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}